Raha Samraat S. (CIK 1738340) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-12). Recent activity: Buy MYGN (3,542 shares), Buy MYGN (618,557 shares), Sell MYGN (36,304 shares), Sell MYGN (10,816 shares), Buy MYGN (40,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | MYRIAD GENETICS INC (MYGN) | President and CEO | Buy | 3,542 | $13,941 |
| 2026-03-16 | MYRIAD GENETICS INC (MYGN) | President and CEO | Buy | 618,557 | $0 |
| 2026-03-16 | MYRIAD GENETICS INC (MYGN) | President and CEO | Sell | 36,304 | $169,177 |
| 2026-03-16 | MYRIAD GENETICS INC (MYGN) | President and CEO | Sell | 10,816 | $50,403 |
| 2026-03-09 | MYRIAD GENETICS INC (MYGN) | President and CEO | Buy | 40,000 | $200,000 |
| 2025-12-12 | MYRIAD GENETICS INC (MYGN) | President and CEO | Sell | 29,634 | $216,328 |
| 2025-06-02 | MYRIAD GENETICS INC (MYGN) | President and CEO | Buy | 1,498 | $5,333 |
| 2025-03-17 | MYRIAD GENETICS INC (MYGN) | Chief Operating Officer | Buy | 216,495 | $0 |
| 2025-03-17 | MYRIAD GENETICS INC (MYGN) | Chief Operating Officer | Sell | 7,649 | $77,025 |
Source: SEC Form 4 filings · as of 2026-06-12